Alleima AB (publ) (STO:ALLEI)
Sweden · Delayed Price · Currency is SEK | Market Cap | 29.43B +66.9% |
| Revenue (ttm) | 18.19B -6.8% |
| Net Income | 912.00M -19.4% |
| EPS | 3.65 -19.2% |
| Shares Out | 250.27M |
| PE Ratio | 32.26 |
| Forward PE | 22.62 |
| Dividend | 2.50 (2.11%) |
| Ex-Dividend Date | Apr 30, 2026 |
| Volume | 17,646 |
| Open | 117.60 |
| Previous Close | 117.60 |
| Day's Range | 116.80 - 117.80 |
| 52-Week Range | 68.65 - 122.90 |
| Beta | 1.10 |
| Analysts | Hold |
| Price Target | 96.75 (-17.45%) |
| Earnings Date | Oct 26, 2026 |
About Alleima AB
Alleima AB (publ) manufactures and sells stainless steels, special alloys, medical wires and components, and electric heating systems in Europe, North America, Asia, and internationally. It operates through three divisions: Tube, Kanthal, and Strip. The company offers tubes for extraction and production of oil and gas, advanced stainless steel, umbilical tubes, control lines, corrosion-resistant alloys, and oil country tubular goods; solid and hollow bar, high-pressure and composite tubing, semi-finished ingots and blooms, and billets; hydrauli... [Read more]
Financial Performance
In 2025, Alleima AB's revenue was 18.63 billion, a decrease of -5.39% compared to the previous year's 19.69 billion. Earnings were 671.00 million, a decrease of -45.05%.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for ALLEI stock is "Hold." The 12-month stock price target is kr 96.75, which is a decrease of -17.45% from the latest price.
News
Alleima downgraded to Hold from Buy at SEB Equities
SEB Equities downgraded Alleima (SAMHF) to Hold from Buy with a SEK 100 price target
Alleima AB Earnings Call Transcript: Q2 2026
Order intake and revenues returned to organic growth, led by strong performance in umbilicals, medical, industrial heating, and aerospace. Kanthal delivered record margins, while cost-saving measures supported profitability amid ongoing market uncertainty and regional volatility.
Alleima AB Quarterly report: Q2 2026
Alleima AB has published its Q2 2026 quarterly earnings report on July 17, 2026.
Alleima AB Slides: Q2 2026
Alleima AB has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 17, 2026.
Alleima AB Slides: Company presentation
Alleima AB has posted slides in relation to its latest quarterly earnings report, which was published on May 1, 2026.
Alleima AB Earnings Call Transcript: Q1 2026
Market uncertainty and Middle East instability led to lower order intake and revenues, but strong performance in medical, industrial heating, and Kanthal segments helped offset declines. Efficiency measures and a solid balance sheet support ongoing investments and resilience.
Alleima AB Quarterly report: Q1 2026
Alleima AB has published its Q1 2026 quarterly earnings report on April 27, 2026.
Alleima AB Slides: Q1 2026
Alleima AB has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 27, 2026.
Alleima AB Slides: Company presentation
Alleima AB has posted slides in relation to its latest quarterly earnings report, which was published on January 30, 2026.
Alleima downgraded to Sell from Hold at Danske Bank
Danske Bank downgraded Alleima (SAMHF) to Sell from Hold with a SEK 68 price target
Alleima AB Earnings Call Transcript: Q4 2025
2025 saw flat organic revenue amid geopolitical and market headwinds, with strong performance in medical, nuclear, and oil & gas offset by weakness in industrial and chem/petrochem. Efficiency measures and capacity expansions are underway, and a strong balance sheet supports continued strategy execution.
Alleima AB Annual report: Q4 2025
Alleima AB has published its Q4 2025 annual report on January 27, 2026.
Alleima AB Quarterly report: Q4 2025
Alleima AB has published its Q4 2025 quarterly earnings report on January 27, 2026.
Alleima AB Slides: Q4 2025
Alleima AB has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on January 27, 2026.
Alleima AB Transcript: CMD 2025
The company is executing a focused strategy to grow high-value segments like medical, nuclear, and industrial heating, supported by strong financials and targeted investments. Margin improvement, operational excellence, and sustainability are key priorities, with ongoing initiatives across all divisions to enhance growth and efficiency.
Alleima AB Slides: FY 2025
Alleima AB has posted slides in relation to its FY 2025 quarterly earnings report, which was published on November 5, 2025.
Alleima AB Earnings Call Transcript: Q3 2025
Order intake and revenues were flat year-over-year amid macroeconomic uncertainty, with strong backlogs in oil and gas, nuclear, and medical segments. Adjusted EBIT margin fell to 4.7% due to weak European markets, FX headwinds, and a maintenance shutdown. SEK 200m in annual savings targeted via restructuring, with a SEK 400m Q4 charge.
Alleima AB Quarterly report: Q3 2025
Alleima AB has published its Q3 2025 quarterly earnings report on October 22, 2025.
Alleima AB Slides: Q3 2025
Alleima AB has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 22, 2025.